FDA Inspection 1175097 — Granules Pharmaceuticals Inc.
The FDA completed an inspection of Granules Pharmaceuticals Inc. on July 22, 2022 in Chantilly, VA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 22, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Chantilly, VA (United States)